This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khelef, N Articles by Guiso, N Search for Related Content PubMed PubMed Citation Articles by Khelef, N Articles by Guiso, N

Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.

Unité de Bactériologie Moléculaire et Médicale, Institut Pasteur, Paris, France.

ABSTRACT

Bordetella pertussis and Bordetella parapertussis are closely related species. Both are responsible for outbreaks of whooping cough in humans and produce similar virulence factors, with the exception of pertussis toxin, specific to B. pertussis. Current pertussis whole-cell vaccine will soon be replaced by acellular vaccines containing major adhesins (filamentous hemagglutinin and pertactin) and major toxin (pertussis toxin). All of these factors are antigens that stimulate a protective immune response in the murine respiratory model and in clinical assays. In the present study, we examined the protective efficacies of these factors, and that of adenylate cyclase-hemolysin, another B. pertussis toxin, against B. parapertussis infection in a murine respiratory model. As expected, pertussis toxin did not protect against B. parapertussis infection, since this bacterium did not express this protein, but the surprising result was that none of the other factors were protective against B. parapertussis infection. Furthermore, B. parapertussis adenylate cyclase-hemolysin, although it protected against B. parapertussis infection, did not protect against B. pertussis infection. Despite a high degree of homology between both B. pertussis and B. parapertussis species, no cross-protection was observed. Our results outline the fact that, as in other gram-negative bacteria, Bordetella surface proteins vary immunologically.

This article has been cited by other articles:

• Andre, P., Caro, V., Njamkepo, E., Wendelboe, A. M., Van Rie, A., Guiso, N. (2008). Comparison of Serological and Real-Time PCR Assays To Diagnose Bordetella pertussis Infection in 2007. J. Clin. Microbiol. 46: 1672-1677 [Abstract] [Full Text]  
• Stefanelli, P., Sanguinetti, M., Fazio, C., Posteraro, B., Fadda, G., Mastrantonio, P. (2006). Differential In Vitro Expression of the brkA Gene in Bordetella pertussis and Bordetella parapertussis Clinical Isolates.. J. Clin. Microbiol. 44: 3397-3400 [Abstract] [Full Text]  
• Wolfe, D. N., Kirimanjeswara, G. S., Harvill, E. T. (2005). Clearance of Bordetella parapertussis from the Lower Respiratory Tract Requires Humoral and Cellular Immunity. Infect. Immun. 73: 6508-6513 [Abstract] [Full Text]  
• Hijnen, M., Mooi, F. R., van Gageldonk, P. G. M., Hoogerhout, P., King, A. J., Berbers, G. A. M. (2004). Epitope Structure of the Bordetella pertussis Protein P.69 Pertactin, a Major Vaccine Component and Protective Antigen. Infect. Immun. 72: 3716-3723 [Abstract] [Full Text]  
• Watanabe, M., Nagai, M. (2003). Role of Systemic and Mucosal Immune Responses in Reciprocal Protection against Bordetella pertussis and Bordetella parapertussis in a Murine Model of Respiratory Infection. Infect. Immun. 71: 733-738 [Abstract] [Full Text]  
• Watanabe, M., Nagai, M. (2001). Reciprocal Protective Immunity against Bordetella pertussis and Bordetella parapertussis in a Murine Model of Respiratory Infection. Infect. Immun. 69: 6981-6986 [Abstract] [Full Text]  
• Trollfors, B., Lagergard, T., Taranger, J., Bergfors, E., Schneerson, R., Robbins, J. B. (2001). Serum Immunoglobulin G Antibody Responses to Bordetella pertussis Lipooligosaccharide and B. parapertussis Lipopolysaccharide in Children with Pertussis and Parapertussis. CVI 8: 1015-1017 [Abstract] [Full Text]  
• Boursaux-Eude, C., Guiso, N. (2000). Polymorphism of Repeated Regions of Pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Infect. Immun. 68: 4815-4817 [Abstract] [Full Text]  
• Bassinet, L., Gueirard, P., Maitre, B., Housset, B., Gounon, P., Guiso, N. (2000). Role of Adhesins and Toxins in Invasion of Human Tracheal Epithelial Cells by Bordetella pertussis. Infect. Immun. 68: 1934-1941 [Abstract] [Full Text]  
• van den Berg, B. M., Beekhuizen, H., Mooi, F. R., van Furth, R. (1999). Role of Antibodies against Bordetella pertussis Virulence Factors in Adherence of Bordetella pertussis and Bordetella parapertussis to Human Bronchial Epithelial cells. Infect. Immun. 67: 1050-1055 [Abstract] [Full Text]  
• He, Q., Viljanen, M. K., Arvilommi, H., Aittanen, B., Mertsola, J. (1998). Whooping Cough Caused by Bordetella pertussis and Bordetella parapertussis in an Immunized Population. JAMA 280: 635-637 [Abstract] [Full Text]  
• Mastrantonio, P., Stefanelli, P., Giuliano, M., Rojas, Y. H., Ciofi degli Atti, M., Anemona, A., Tozzi, A. E. (1998). Bordetella parapertussis Infection in Children: Epidemiology, Clinical Symptoms, and Molecular Characteristics of Isolates. J. Clin. Microbiol. 36: 999-1002 [Abstract] [Full Text]  
• Mooi, F. R., van Oirschot, H., Heuvelman, K., van der Heide, H. G. J., Gaastra, W., Willems, R. J. L. (1998). Polymorphism in the Bordetella pertussis Virulence Factors P.69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution. Infect. Immun. 66: 670-675 [Abstract] [Full Text]  
• Stehr, K., Cherry, J. D., Heininger, U., Schmitt-Grohe, S., Uberall, M., Laussucq, S., Eckhardt, T., Meyer, M., Engelhardt, R., Christenson, P., the Pertussis Vaccine Study Group, (1998). A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine. Pediatrics 101: 1-11 [Abstract] [Full Text]